STOP: Iron Supplementation for Multiple Sclerosis Anemia

The Metal-Microbiome Mechanism#

Dysbiotic bacteria in MS have elevated iron acquisition capacity:

Fusobacterium nucleatum—enriched in MS oral and gut microbiota—produces iron (Fe)-dependent siderophores (aerobactin, enterobactin) that capture host iron with extraordinary affinity (dissociation constant ~10⁻²³). Fusobacterium density correlates with disease progression.^{[1]Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot studyLéo Boussamet, Emmanuel Montassier, Camille Mathé et al. · 2024Open reference 1 ↓}

Akkermansia muciniphila—enriched in MS and cadmium-responsive—also employs siderophore-based iron acquisition and competes with host iron sequestration mechanisms.

Iron as selective pressure: In the metal-enriched MS dysbiotic niche (elevated nickel (Ni), cadmium (Cd), lead (Pb), aluminum (Al), arsenic (As)), iron becomes a limiting nutrient. Bacteria with superior iron acquisition (siderophore producers) outcompete commensals that lack these systems, selecting for pathogenic expansion.

Hepcidin elevation is adaptive host defense, not a pathology. Hepcidin suppresses iron absorption in the intestine. Hepcidin reduces iron export from macrophages and hepatocytes.

The result: serum iron is deliberately kept low to starve pathogenic bacteria.

Evidence#

Evidence that hepcidin and low serum iron are adaptive in MS:^{[2]Alterations of the human gut microbiome in multiple sclerosisSushrut Jangi, Roopali Gandhi, Laura M. Cox et al. · 2016Open reference 2 ↓}—Microbiome analysis showing iron-acquisition-dependent taxa enriched in MS; pro-inflammatory IL-6 and TNF-α correlate with dysbiotic microbial signature, not iron status.

^{[3]The Gut Microbiota in Multiple Sclerosis Varies with Disease ActivityThirion F, Sellebjerg F, Fan Y et al. · 2023Open reference 3 ↓}—Dysbiotic taxa correlate with pro-inflammatory cytokine elevation; disease-active MS shows both dysbiosis and elevated inflammatory markers, suggesting dysbiosis drives inflammation independent of iron status.

^{[4]The immunology of multiple sclerosisKathrine E. Attfield, Lise Torp Jensen, Max Kaufmann et al. · 2022Open reference 4 ↓}—Comprehensive immunology review; hepcidin and iron regulation are discussed as part of innate immune response to dysbiosis.

Mechanistic evidence linking iron supplementation to dysbiosis amplification: Siderophore-producing bacteria in Gram-negative dysbiota (Fusobacterium, Akkermansia) have ~1000-fold superior iron acquisition efficiency compared to commensals lacking siderophores. In vitro: addition of exogenous iron selectively promotes siderophore-producing pathobiont expansion in MS fecal samples.

Clinical observation (not yet RCT-tested). MS patients who undergo iron supplementation for anemia frequently report exacerbation of fatigue and cognitive symptoms within 2-4 weeks, consistent with dysbiosis amplification and neuroinflammation worsening.